Shared on04 Aug 25Fair value Decreased 6.09%
Despite an improved revenue growth outlook and a lower forward P/E multiple, ArcBest’s consensus analyst price target has been revised downward from $94.42 to $89.67. What's in the News ArcBest completed a buyback tranche, repurchasing 209,913 shares for $14.46 million, totaling 6,599,478 shares or 26.72% repurchased under the program since inception.
Shared on17 Apr 25Fair value Decreased 6.40%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 5.44%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 1.79%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 6.81%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Increased 34%
AnalystConsensusTarget has increased revenue growth from 3.5% to 5.2%, decreased profit margin from 4.8% to 3.8% and increased future PE multiple from 13.0x to 16.9x.